Sylvia Adams Selected Research

Sylvia Adams Research Topics

Disease

56	Neoplasms (Cancer) 08/2023 - 10/2004
48	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2010
17	Triple Negative Breast Neoplasms 04/2024 - 01/2013
9	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2012
8	Melanoma (Melanoma, Malignant) 12/2019 - 07/2007
4	Disease Progression 01/2023 - 01/2017
4	Testicular Neoplasms (Testicular Cancer) 03/2015 - 07/2007
3	Brain Neoplasms (Brain Tumor) 04/2024 - 11/2017
2	Pathologic Complete Response 01/2023 - 01/2020
2	Neutropenia 01/2020 - 03/2014
2	Necrosis 10/2019 - 05/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2019 - 09/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018 - 11/2017
2	Carcinoma (Carcinomatosis) 11/2017 - 05/2015
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	COVID-19 01/2022
1	Pleural Effusion (Pleural Effusions) 10/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2021
1	Genomic Instability 11/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Autoimmune Hepatitis 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Liver Failure 01/2020
1	Fatigue 01/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2019
1	Carcinoma in Situ 10/2018
1	Neoplasm Micrometastasis 09/2018
1	Margins of Excision 09/2018
1	Starvation 11/2017

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2013
10	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2016
9	130-nm albumin-bound paclitaxelIBA 11/2021 - 01/2016
7	atezolizumabIBA 11/2021 - 11/2018
7	Imiquimod (Aldara)FDA LinkGeneric 12/2019 - 07/2008
7	AntigensIBA 10/2018 - 07/2007
6	B7-H1 AntigenIBA 12/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 03/2015 - 05/2007
4	Estrogen ReceptorsIBA 01/2023 - 01/2016
4	Hematoxylin (Haematoxylon)IBA 01/2023 - 09/2014
4	CytokinesIBA 01/2019 - 11/2008
4	Hormones (Hormone)IBA 11/2018 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2023 - 11/2008
3	pembrolizumabIBA 01/2023 - 01/2017
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2023 - 09/2015
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
3	taxaneIBA 01/2021 - 11/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 08/2017 - 12/2010
3	MART-1 AntigenIBA 08/2011 - 08/2008
2	Peptides (Polypeptides)IBA 01/2023 - 07/2007
2	IpilimumabIBA 01/2022 - 08/2011
2	PlatinumIBA 01/2020 - 03/2014
2	Monoclonal AntibodiesIBA 01/2019 - 10/2018
2	human ERBB2 proteinIBA 11/2018 - 01/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2018 - 12/2012
2	Toll-Like Receptor AgonistsIBA 10/2018 - 11/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2018 - 12/2012
2	Matrix Metalloproteinase InhibitorsIBA 01/2018 - 10/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 10/2016
2	Epidermal Growth Factor (EGF)IBA 08/2017 - 10/2016
2	Monatide (IMS 3015)IBA 03/2015 - 05/2007
2	Toll-Like Receptor 7IBA 12/2012 - 12/2012
2	Monophenol Monooxygenase (Tyrosinase)IBA 08/2011 - 08/2008
2	Vaccine AdjuvantsIBA 11/2009 - 07/2008
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Tamoxifen FDA LinkGeneric 11/2022
1	Aromatase InhibitorsIBA 11/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	InterferonsIBA 10/2021
1	monophosphoryl lipid AIBA 10/2021
1	SodiumIBA 01/2021
1	Protons (Proton)IBA 01/2021
1	trans-sodium crocetinate (crocetin)IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2020
1	Phenobarbital (Luminal)FDA Link 11/2020
1	DNA Repair EnzymesIBA 11/2020
1	ChemokinesIBA 12/2019
1	LigandsIBA 01/2019
1	Chemokine CXCL10IBA 01/2019
1	Blocking AntibodiesIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 10/2018
1	Cytotoxins (Cytolysins)IBA 10/2018
1	exemestane (Aromasin)FDA Link 02/2018
1	fresolimumabIBA 01/2018
1	Oxygen (Dioxygen)IBA 11/2017
1	Glutathione (Reduced Glutathione)IBA 11/2017
1	IronIBA 11/2017
1	EnzymesIBA 11/2017

Therapy/Procedure

26	Therapeutics 04/2024 - 11/2008
12	Immunotherapy 01/2021 - 10/2004
10	Drug Therapy (Chemotherapy) 11/2022 - 05/2015
6	Radiotherapy 09/2018 - 12/2010
3	Neoadjuvant Therapy 01/2023 - 09/2018
2	Adjuvant Chemotherapy 09/2015 - 05/2015
1	Biological Therapy 01/2022
1	Segmental Mastectomy (Lumpectomy) 10/2019
1	Mastectomy (Mammectomy) 09/2018